Evidence map›Paper›PMID 36466913›Full record

ArticleFrontiers in immunology2022

Neutrophils inhibit γδ T cell functions in the imiquimod-induced mouse model of psoriasis.

Sara Costa, Dalila Bevilacqua, Elena Caveggion, Sara Gasperini, Elena Zenaro, Francesca Pettinella, Marta Donini, Stefano Dusi, Gabriela Constantin, Silvia Lonardi and 11 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The Role of NADPH Oxidase 2 in Leukocytes.Antioxidants (Basel, Switzerland) · 2025
    Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 2 countries.

Sara CostaDepartment of Medicine, Division of General Pathology, University of Verona, Verona, Italy.
Dalila BevilacquaDepartment of Medicine, Division of General Pathology, University of Verona, Verona, Italy.
Elena CaveggionDepartment of Medicine, Division of General Pathology, University of Verona, Verona, Italy.
Sara GasperiniDepartment of Medicine, Division of General Pathology, University of Verona, Verona, Italy.
Elena ZenaroDepartment of Medicine, Division of General Pathology, University of Verona, Verona, Italy.
Francesca PettinellaDepartment of Medicine, Division of General Pathology, University of Verona, Verona, Italy.
Marta DoniniDepartment of Medicine, Division of General Pathology, University of Verona, Verona, Italy.
Stefano DusiDepartment of Medicine, Division of General Pathology, University of Verona, Verona, Italy.
Gabriela ConstantinDepartment of Medicine, Division of General Pathology, University of Verona, Verona, Italy.
Silvia LonardiDepartment of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
William VermiDepartment of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
Francesco De SanctisDivision of Immunology, University of Verona, Verona, Italy.
Stefano UgelDivision of Immunology, University of Verona, Verona, Italy.
Tiziana CestariDivision of Immunology, University of Verona, Verona, Italy.
Clare L AbramDepartment of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, United States.
Clifford A LowellDepartment of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, United States.
Pamela RodegherDepartment of Diagnostics and Public Health, Unit of Forensic Medicine, University of Verona, Verona, Italy.
Franco TagliaroDepartment of Diagnostics and Public Health, Unit of Forensic Medicine, University of Verona, Verona, Italy.
Giampiero GirolomoniDivision of Dermatology and Venereology, University of Verona, Verona, Italy.
Marco A CassatellaDepartment of Medicine, Division of General Pathology, University of Verona, Verona, Italy.
Patrizia ScapiniDepartment of Medicine, Division of General Pathology, University of Verona, Verona, Italy.
University of Verona · ITUniversity of Brescia · ITUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Psoriasis is a chronic skin disease associated with deregulated interplays between immune cells and keratinocytes. Neutrophil accumulation in the skin is a histological feature that characterizes psoriasis. However, the role of neutrophils in psoriasis onset and development remains poorly understood. Methods: In this study, we utilized the model of psoriasiform dermatitis, caused by the repeated topical application of an imiquimod containing cream, in neutrophil-depleted mice or in mice carrying impairment in neutrophil functions, including p47phox -/- mice (lacking a cytosolic subunit of the phagocyte nicotinamide adenine dinucleotide phosphate - NADPH - oxidase) and Sykfl/fl MRP8-cre+ mice (carrying the specific deletion of the Syk kinase in neutrophils only), to elucidate the specific contribution of neutrophils to psoriasis development. Results: By analyzing disease development/progression in neutrophil-depleted mice, we now report that neutrophils act as negative modulators of disease propagation and exacerbation by inhibiting gammadelta T cell effector functions via nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-mediated reactive oxygen species (ROS) production. We also report that Syk functions as a crucial molecule in determining the outcome of neutrophil and γδ T cell interactions. Accordingly, we uncover that a selective impairment of Syk-dependent signaling in neutrophils is sufficient to reproduce the enhancement of skin inflammation and γδ T cell infiltration observed in neutrophil-depleted mice. Conclusions: Overall, our findings add new insights into the specific contribution of neutrophils to disease progression in the IMQ-induced mouse model of psoriasis, namely as negative regulatory cells.

Indexed as

EczemaPsoriasisAnimalsDisease Models, AnimalDisease ProgressionImiquimodMiceNADPNADPH OxidasesNeutrophilsImiquimodNADPNADPH Oxidasesgamma delta (gammadelta) T cellsimmunoregulationinflammatory cyotokinesneutrophilsskin inflammation

Identifiers

PMID36466913
PMCPMC9709482
OpenAlexW4309317209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.